C World Wide Group Holding A Incyte Corp Transaction History

C World Wide Group Holding A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$73.52 - $88.7 $2.85 Million - $3.43 Million	-38,726 Closed	0 $0
Q1 2019 May 03, 2019	SELL	$63.56 - $88.17 $365,660 - $507,242	-5,753 Reduced 12.93%	38,726 $3.33 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $148,824 - $177,927	-2,544 Reduced 5.41%	44,479 $2.83 Million
Q3 2018 Nov 05, 2018	BUY	$61.75 - $74.23 $73,914 - $88,853	1,197 Added 2.61%	47,023 $3.25 Million
Q2 2018 Aug 03, 2018	BUY	$60.85 - $83.98 $544,668 - $751,704	8,951 Added 24.27%	45,826 $3.07 Million
Q1 2018 May 03, 2018	SELL	$83.06 - $100.98 $1.1 Million - $1.34 Million	-13,301 Reduced 26.51%	36,875 $3.07 Million
Q4 2017 Feb 07, 2018	SELL	$93.56 - $116.6 $2.41 Million - $3 Million	-25,765 Reduced 33.93%	50,176 $4.75 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $8.29 Million - $10.5 Million	75,941	75,941 $8.87 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.